RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Investor Relations

Home  >  Investor Relations  >  Overview

QIAGEN and EQT agree on all-cash takeover offer

QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer.

QIAGEN Deep Dives

Explore our Deep Dive event series for in-depth insights into QIAGEN’s portfolio and growth ambitions.

Capital Markets Day 2024

Visit our Capital Markets Day 2024 microsite to learn more about our commitment to solid profitable growth.


Events & Presentations

View all events & presentations